Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from Iqvia

Beyond Biotech—3 Healthcare Stocks for Growth-Minded Investors

Healthcare stocks rebounded in 2025. These three healthcare growth stocks offer exposure to innovation beyond traditional biotech risk

MarketBeat

What You Need To Know Ahead of IQVIA’s Earnings Release

Here’s what you need to know before life sciences analytics company IQVIA reports its Q4 earnings.

Barchart

Is IQVIA Holdings Stock Outperforming the S&P 500?

IQVIA Holdings has significantly outperformed the broader S&P 500 Index in recent months, and analysts remain strongly bullish on the stock’s prospects.

Barchart

From analysis to the latest developments in health,
read the most diverse news in one place.

Sunshine Biopharma Stock Is Surging Thursday: Here's What's Happening

Shares of Sunshine Biopharma Inc. (NASDAQ:SBFM) are trading higher Thursday after the Florida-based pharmaceutical company announced the launch of a generic prescription drug.

Benzinga

What to Expect From IQVIA Holdings’ Next Quarterly Earnings Report

IQVIA Holdings is gearing up to release its third-quarter earnings later this month, and analysts project a steady single-digit increase in profitability.

Barchart

How Is IQVIA Holdings' Stock Performance Compared to Other Health Tech Stocks?

Although IQVIA has lagged behind its health tech peers over the past year, Wall Street analysts maintain a highly confident outlook on the stock’s future performance.

Barchart

IQVIA Stock: Is Wall Street Bullish or Bearish?

Although IQVIA has lagged behind the broader market over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

Barchart

Read news from The Economist, FT, and more,
with one subscription

Here's What to Expect from IQVIA Holdings' Next Earnings Report

IQVIA Holdings is gearing up to announce its Q1 results in the next month, and analysts expect a single-digit growth in earnings.

Barchart

Is IQVIA Holdings Stock Underperforming the Dow?

IQVIA Holdings has significantly underperformed the Dow over the past year, yet analysts remain strongly bullish on the stock’s prospects.

Barchart

IQVIA Holdings Stock: Analyst Estimates & Ratings

IQVIA Holdings has trailed the broader market over the past year, but analysts on Wall Street maintain a very bright outlook on the stock’s growth prospects.

Barchart

Nvidia Could Power Up This Under-the-Radar Healthcare Stock

A partnership with Nvidia is bound to yield fruitful results for this little-known company.

Barchart

3 Semiconductor Innovators Powering Tomorrow’s Technologies

From cutting-edge AI chips to energy-efficient solutions, semiconductor stocks are driving innovation across industries. Amid this backdrop, it could be wise for investors to add NVIDIA Corp (NVDA), Broadcom (AVGO), and QUALCOMM (QCOM) to their watchlists. Read more….

StockNews.com

Earnings Preview: What to Expect From IQVIA Holdings' Report

IQVIA Holdings will release its fourth-quarter earnings next month, and analysts anticipate a single-digit bottom-line growth.

Barchart

This Little-Known Healthcare Company Has a ‘Strong Buy’ Rating and a New Nvidia Partnership

The company will leverage Nvidia’s prowess in AI to build proprietary models.

Barchart

Get all your
news in one place.

100’s of premium titles.
One news app.

Barchart

Is IQVIA Holdings Stock Underperforming the Nasdaq?

IQVIA Holdings has considerably underperformed the Nasdaq over the past year, but analysts are highly optimistic about the stock’s prospects.

Barchart

Do Wall Street Analysts Like IQVIA Holdings Stock?

IQVIA Holdings has underperformed the broader market over the past year, but Wall Street analysts are bullish about the stock’s prospects.

Barchart

IQVIA Holdings' Quarterly Earnings Preview: What You Need to Know

With IQVIA Holdings gearing up to release its third-quarter earnings later this month, analysts project a double-digit surge in earnings.

Kiplinger

Best Strong Buy Stocks for a Stock Picker's Market

Current market conditions have folks seeking out sturdy investment opportunities. These Strong Buy stocks are a good place to start.

Get all your
news in one place.

100’s of premium titles.
One news app.

The Independent UK

What's behind shortages of Adderall, Ozempic and other meds?

Drug shortages are growing in the United States, and experts see no clear path to resolving them

Axios

Adderall shortage puts U.S. on brink of public health crisis

A rise in demand for Adderall has triggered a shortage of the drug.

Benzinga

BLRX: September NDA

By John Vandermosten, CFA NASDAQ:BLRX READ THE FULL BLRX RESEARCH REPORT

The Hindu

Maker of Dolo-650, pandemic’s ‘magic pill’, faces income tax searches and PIL petitions

National trade union of medical representatives cites paracetamol to make a case against unethical marketing practices of pharma companies

Asharq Al-Awsat

Saudi Arabia, US Sign 18 Agreements in Energy, Other Areas

Saudi Arabia and the United States signed 18 partnership agreements in fields including energy, communications, space and healthcare during a visit by US President Joe Biden. The agreements include deals with US aerospace and defense firms Boeing and Raytheon, as well as healthcare companies Medtronic, Digital Diagnostics, and IQVIA, according…

Benzinga

Investors Seem To Be Unmoved By IQVIA's Street Lagging Estimates, Q1 Surpass Expectations

IQVIA Holdings Inc (NYSE:IQV) posted Q1 sales of $3.57 billion, up 4.7% on a reported basis and 6.8% at constant currency (CC), slightly above the consensus of $3.55 billion. Technology & Analytics Solutions revenue increased 6.8% (9.8% CC) to $1.44 billion. Research & Development Solutions (R&DS) sales reached $1.93 billion, +3.5% (4.7%…

StockNews.com

3 Beaten-Down Growth Stocks to Snatch Up in Q2 2022

Despite no clarity on when the Russia-Ukraine war will end, surging inflation, and logistical hindrances, the U.S. economy looks sufficiently resilient to weather the crises. Given this backdrop, we think shares of beaten-down growth stocks IQVIA (IQV), West Pharmaceutical (WST), and Synopsys (SNPS) could soar in price in the coming…

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.